Showing 1351-1360 of 1564 results for "".
- Small Percentage of Ophthalmologists Perform Large Proportion of Intravitreal Anti-VEGF Injectionshttps://modernod.com/news/small-percentage-of-ophthalmologists-perform-large-proportion-of-intravitreal-anti-vegf-injections/2476712/Three percent of ophthalmologists perform 17% to 31% of all anti-vascular endothelial growth factor (VEGF) injections in the U.S., depending on the agent used, according to new findings, as reported by Reuters. “More important
- RightEye, USA Baseball and Optometrists Team Up to Improve Players’ Athletic Abilities Through Sports Visionhttps://modernod.com/news/righteye-usa-baseball-and-optometrists-team-up-to-improve-players-athletic-abilities-through-sports-vision/2476677/RightEye announced that it is working with USA Baseball for the third consecutive year to provide baseline sports vision assessment to all athletes entering the Prospect Development Pipeline (PDP), a collaboration bet
- FDA Wins Case Against Florida Stem Cell Clinic that Harmed three Women’s Visionhttps://modernod.com/news/fda-wins-case-against-florida-stem-cell-clinic-that-harmed-three-womens-vision/2476631/The FDA has won a federal judge’s backing for its efforts to crack down on the rapidly growing stem cell industry that promises all kinds of unproven treatments for serious diseases, according to an NBC News
- Schwind Introduces WiseNET Intelligent Web-Based Databasehttps://modernod.com/news/schwind-introduces-wisenet-intelligent-web-based-database/2476554/Schwind WiseNET is a web-based database that allows the user to capture and evaluate refractive treatment data quickly and precisely, and present it graphically for all sorts of uses in daily clinical work. Diagrams s
- Nicox Signs Agreement for Zerviate in China for Up to €17 Million in Milestone Payments Plus Royaltieshttps://modernod.com/news/nicox-signs-agreement-for-zerviate-in-china-for-up-to-e17-million-in-milestone-payments-plus-royalties/2476381/Nicox SA and Ocumension Therapeutics announced they have entered into an exclusive license agreement for the development and commercialization of Nicox’s product Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of all
- College of Optometrists in Vision Development & NORA Issue Joint Recommendation for Optometric Evaluation Following Brain Injuryhttps://modernod.com/news/college-of-optometrists-in-vision-development-nora-issue-joint-recommendation-for-optometric-evaluation-following-brain-injury/2476285/The College of Optometrists in Vision Development (COVD) and the Neuro Optometric Rehabilitation Association (NORA) issued a joint call-to-action to all healthcare professionals to consider the need for medical and/or functional optometric rehabilitation services for patients who have suffered a
- USPSTF Reaffirms Advice on Prevention of Gonococcal Eye Infections in Newbornshttps://modernod.com/news/uspstf-reaffirms-advice-on-prevention-of-gonococcal-eye-infections-in-newborns/2476334/The U.S. Preventive Services Task Force (USPSTF) continues to recommend that all newborns be treated with a topical antibiotic ointment to prevent gonococcal eye infections, according to a Reuters report. This “A” recom
- 2018 Best of Eyetubehttps://modernod.com/news/2018-best-of-eyetube/2476238/Cataract & Refractive Surgery Today (CRST) has compiled the best content of 2018 from Eyetube.net, the leading video resource for ophthalmologists. Below are descriptions of a few of the top videos. To view all of the videos and their descriptions, click
- Dry Eye Symptom Screens Show Modest Accuracyhttps://modernod.com/news/dry-eye-symptom-screens-show-modest-accuracy/2479636/In head-to-head comparisons, two of five dry eye screens showed a statistically significant ability to detect signs of the disorder, but all demonstrated relatively modest diagnostic accuracy, researchers say, according to a Reuters report
- T-Cell Immune Responses Drive Neurodegeneration in Glaucomahttps://modernod.com/news/t-cell-immune-responses-drive-neurodegeneration-in-glaucoma/2479933/T-cell immune responses are partly responsible for progressive neurodegeneration in glaucoma, researchers report. “Current treatment of glaucoma is almost all focused on reducing intraocular pressure (IOP) and amelioration of